Fluocinolone acetonide intraviteal implant

BNF:: 11.4.1
Status:: Do Not Prescribe (DNP), Red
Decision Date:: December 2013

Comments

RED:

NICE TA953 - for treating chronic diabetic macular oedema. (Replaces TA301 and TA613) (Decision date - April 2024)
NICE TA590 - for treating recurrent non-infectious uvetitis. (Decision date - August 2019)

Black Drug Classifications

6: Have NICE guidance that recommends they should not be used

Red Drug Classifications

1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)